Merck Reports Good News/Bad News In Latest Keytruda Readouts

 
• By Joseph Haas
  
Good & Bad
Merck's Keytruda showed benefit in biliary cancer, but not prostate • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D